<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level, glycosylated <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> (HBA1) and <z:chebi fb="0" ids="24103">fructosamine</z:chebi> (FA) were measured in 37 non-diabetic patients with a recent (48 h) <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> of the carotid territory </plain></SENT>
<SENT sid="1" pm="."><plain>The severity of <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> was assessed on admission, and in the 2nd week and 1st month </plain></SENT>
<SENT sid="2" pm="."><plain>The functional outcome and fatality rate was estimated after 1 month </plain></SENT>
<SENT sid="3" pm="."><plain>On the basis of elevated the HBA1 concentration the group of 54% patients was diagnosed to have prestroke <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> predating <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> did not influence fasting glycemia during the few days after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration but not the preceding 2-3 months and 2-3 weeks glycemia correlated strongly with the severity of <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> and predicted <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome </plain></SENT>
<SENT sid="6" pm="."><plain>Measurement of HBA1 seems to be useful as a screening test for mild, clinically silent <z:mp ids='MP_0002055'>diabetes</z:mp> in patients without other risk factors for cerebral <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>